Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients
Clinical trial NCT00770146 · COMPLETED
Trial details
- NCT number
- NCT00770146
- Sponsor
- Kastle Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-05-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.